Internal Medicine, Cardiovascular Disease · New York, NY
NPI
1427109826
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
407 E 70th St
New York, NY, 10021
Phone (212) 861-3222
Medicare paid, 2024
$8,841
134 services
Medicare patients, 2024
30
Average age 76
Drug cost, 2024
$4.4M
11,834 prescriptions
Company payments, 2025
$312
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David S Blumenthal was code 93000 (electrocardiogram), 24 times for 20 patients. In total David S Blumenthal billed 134 services in 25 codes, and Medicare paid $8,841.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 24 | 20 | $11.62 | $279 |
| 36415 Venipuncture Blood Collection | Office | 21 | 17 | $8.45 | $177 |
| 99215 Office E&M - Established | Office | 20 | 18 | $146.74 | $2,935 |
| 93306 Echocardiography (TTE/TEE) | Office | 13 | 12 | $166.96 | $2,170 |
By year: 2022 $5,243 for 104 services; 2023 $6,012 for 104 services; 2024 $8,841 for 134 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 21 | 17 | $8.45 | $177 |
Medicare prescription drug claims, 2024
In 2024, the drug David S Blumenthal prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,240 prescriptions and refills. In total David S Blumenthal wrote 11,834 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,240 | 3,455 | 349 | $24K |
| Ezetimibe Generic | 922 | 2,575 | 281 | $27K |
| Amlodipine Besylate Generic | 726 | 1,839 | 194 | $5,966 |
| Eliquis Apixaban | 616 | 1,073 | 124 | $608K |
| Metoprolol Succinate Generic | 532 | 1,331 | 150 | $9,543 |
| Atorvastatin Calcium Generic | 488 | 1,259 | 131 | $5,303 |
| Repatha Sureclick Evolocumab | 457 | 636 | 68 | $359K |
| Eplerenone Generic | 361 | 867 | 94 | $29K |
| Praluent Pen Alirocumab | 312 | 427 | 46 | $214K |
| Hydrochlorothiazide Generic | 297 | 741 | 88 | $1,901 |
| Irbesartan Generic | 292 | 717 | 77 | $6,009 |
| Levothyroxine Sodium Generic | 276 | 790 | 83 | $4,438 |
| Valsartan Generic | 251 | 715 | 72 | $6,474 |
| Zolpidem Tartrate Generic | 239 | 239 | 45 | $1,567 |
| Carvedilol Generic | 190 | 412 | 43 | $1,522 |
Brand drugs: 2,553 claims; generic drugs: 9,281 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David S Blumenthal $312 ($312 in general payments such as food, travel and fees) from 4 companies. The largest payer was Novartis Pharmaceuticals Corporation with $212.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.